$BHVN

$12.07▲ +1.5% YTD

4 SEC 13D/G filings tracked · Last updated Oct 8, 2026

Filing History

CP $12.07▲ +1.5%Oct 8, 2026 · ThinkSabio Blog

$BHVN Licensing Agreement with Ono Pharma for Extracellular IgG Degraders in Japan and Select Asian Regions. Biohaven to receive $80M upfront…

News

BHVN ▼ -0.1% - Biohaven Ltd.

CP $11.88▲ -0.1%Oct 8, 2026 · ThinkSabio Blog

$BHVN - Biohaven Enters Strategic Licensing Agreement with Ono Pharma for Extracellular IgG Degraders in Japan and Select Asian Regions, Lead Candidat…

News

BHVN ▼ -0.7% - Biohaven Ltd.

CP $12.91▲ -0.7%Sep 28, 2026 · ThinkSabio Blog

$BHVN - Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presen…

SEC 13D/G

$BHVN SEC Filing Update (08-JUL-2026) | ThinkSabio - Stocks Simplified

$16.80▲ 54.98%Jul 8, 2026 · ThinkSabio Blog

$BHVN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #BHVN : $16.80 Sector: Healthcare | YTD: 🔼+ 54.98% The SEC discl…